section name header

Pronunciation

soo-doe-e-FED-rin

Classifications

Therapeutic Classification: allergy, cold and cough remedies, nasal drying agents/decongestants

Pharmacologic Classification: adrenergics, alpha adrenergic agonists

Indications

REMS


Action

  • Stimulates alpha- and beta-adrenergic receptors.
  • Produces vasoconstriction in the respiratory tract mucosa (alpha-adrenergic stimulation) and possibly bronchodilation (beta2-adrenergic stimulation).
Therapeutic effects:
  • Reduction of nasal congestion, hyperemia, and swelling in nasal passages.

Pharmacokinetics

Absorption: Well absorbed after oral administration.

Distribution: Appears to enter the CSF.

Metabolism/Excretion: Partially metabolized by the liver. 55–75% excreted unchanged by the kidneys (depends on urine pH).

Half-Life: Children: 3.1 hr; Adults: 9–16 hr (depends on urine pH).

Time/Action Profile

(decongestant effects)

ROUTEONSETPEAKDURATION
PO15–30 minunknown4–6 hr
PO-ER60 minunknown12 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: palpitations, CARDIOVASCULAR COLLAPSE, hypertension, tachycardia

Derm: diaphoresis

GI: anorexia, dry mouth

GU: dysuria

Neuro: anxiety, nervousness, dizziness, drowsiness, excitability, fear, hallucinations, headache, insomnia, restlessness, SEIZURES, weakness

Resp: respiratory difficulty

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Silfedrine Children's, Sudafed 12 Hour, Sudafed 24 Hour, Sudafed Children's, SudoGest, SudoGest 12 Hour

Code

NDC Code